Background: This study examined brain tissue integrity in sites that controls cognition (prefrontal cortices; PFC) and its relationships to glycemic outcomes in adults with type 2 diabetes mellitus (T2DM). Methods: We examined 28 T2DM patients (median age 57.1 years; median body mass index [BMI] 30.6 kg/m 2 ;11 males) and 47 healthy controls (median age 55.0 years; median BMI 25.8 kg/m 2 ; 29 males) for cognition (Montreal Cognitive Assessment [MoCA]), glycemic control (hemoglobin A1c [HbA1c]), and PFC tissue status via brain magnetic resonance imaging (MRI). High-resolution T1-weighted images were collected using a 3.0-Tesla MRI scanner, and PFC tissue changes (tissue density) were examined with voxel-based morphometry procedures. Results: Reduced PFC density values were observed in T2DM patients compared to controls (left, 0.41 ± 0.02 mm 3 /voxel vs 0.44 ± 0.02 mm 3 /voxel, P < 0.001; right, 0.41 ± 0.03 mm 3 /voxel vs 0.45 ± 0.02 mm 3 /voxel, P < 0.001).PFC density values were positively correlated with cognition; left PFC region (r = 0.53, P = 0.005) and right PFC region (r = 0.56, P = 0.003), with age and sex as covariates. Significant negative correlations were found between PFC densities and HbA1c values; left PFC region (r = −0.39, P = 0.049) and right PFC region (r = −0.48, P = 0.01), with age and sex as covariates. Conclusions: T2DM patients showed PFC brain tissue damage, which is asso-